These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27064029)

  • 21. Myeloid ALX/FPR2 regulates vascularization following tissue injury.
    Sansbury BE; Li X; Wong B; Patsalos A; Giannakis N; Zhang MJ; Nagy L; Spite M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14354-14364. PubMed ID: 32513697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the Activation Mechanism of the ALX/FPR2 Receptor.
    Schmitz Nunes V; Rogério AP; Abrahão O
    J Phys Chem Lett; 2020 Nov; 11(21):8952-8957. PubMed ID: 33030905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
    Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
    J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.
    Smith HK; Gil CD; Oliani SM; Gavins FN
    FASEB J; 2015 May; 29(5):2161-71. PubMed ID: 25690650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949.
    Stalder AK; Lott D; Strasser DS; Cruz HG; Krause A; Groenen PM; Dingemanse J
    Br J Clin Pharmacol; 2017 Mar; 83(3):476-486. PubMed ID: 27730665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
    Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
    Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoxin A
    Gaudin A; Tolar M; Peters OA
    Sci Rep; 2018 Jun; 8(1):8921. PubMed ID: 29892010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FPR2/ALX activation reverses LPS-induced vascular hyporeactivity in aorta and increases survival in a pneumosepsis model.
    Horewicz VV; Crestani S; de Sordi R; Rezende E; Assreuy J
    Eur J Pharmacol; 2015 Jan; 746():267-73. PubMed ID: 25478948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis.
    Li A; Zhang L; Li J; Fang Z; Li S; Peng Y; Zhang M; Wang X
    J Cell Mol Med; 2020 Nov; 24(22):13397-13407. PubMed ID: 33025767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis.
    Zhu X; Peng X; Lin J; Zhang Y; He H; Zhao G
    Int Immunopharmacol; 2021 Jul; 96():107785. PubMed ID: 34162149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
    Kang JW; Lee SM
    Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
    Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mast cells mediate early neutrophil recruitment and exhibit anti-inflammatory properties via the formyl peptide receptor 2/lipoxin A
    Hughes EL; Becker F; Flower RJ; Buckingham JC; Gavins FNE
    Br J Pharmacol; 2017 Jul; 174(14):2393-2408. PubMed ID: 28471519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for lipoxin A₄ as an anti-inflammatory mediator in the human endometrium.
    Macdonald LJ; Boddy SC; Denison FC; Sales KJ; Jabbour HN
    Reproduction; 2011 Aug; 142(2):345-52. PubMed ID: 21555360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemin impairs resolution of inflammation via microRNA-144-3p-dependent downregulation of ALX/FPR2.
    Sun G; Lu Y; Zhao L; Xia W; Zhang H; Wang L; Zhang L; Wen A
    Transfusion; 2019 Jan; 59(1):196-206. PubMed ID: 30499593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions.
    Norling LV; Dalli J; Flower RJ; Serhan CN; Perretti M
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1970-8. PubMed ID: 22499990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.
    Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C
    Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial disruptions, but not immune cell invasion, induced secretory dysfunction following innate immune activation in a novel model of acute salivary gland injury.
    Shaalan A; Carpenter G; Proctor G
    J Oral Pathol Med; 2018 Feb; 47(2):211-219. PubMed ID: 29160910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways.
    Bozinovski S; Anthony D; Anderson GP; Irving LB; Levy BD; Vlahos R
    Pharmacol Ther; 2013 Dec; 140(3):280-9. PubMed ID: 23880288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15-epi-Lipoxin A
    Sham HP; Walker KH; Abdulnour RE; Krishnamoorthy N; Douda DN; Norris PC; Barkas I; Benito-Figueroa S; Colby JK; Serhan CN; Levy BD
    J Immunol; 2018 Apr; 200(8):2757-2766. PubMed ID: 29523657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.